vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and IREN Ltd (IREN). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $184.7M, roughly 1.5× IREN Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -84.1%, a 84.9% gap on every dollar of revenue. On growth, IREN Ltd posted the faster year-over-year revenue change (59.0% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-468.0M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada.

HCM vs IREN — Head-to-Head

Bigger by revenue
HCM
HCM
1.5× larger
HCM
$270.8M
$184.7M
IREN
Growing faster (revenue YoY)
IREN
IREN
+75.6% gap
IREN
59.0%
-16.5%
HCM
Higher net margin
HCM
HCM
84.9% more per $
HCM
0.7%
-84.1%
IREN
More free cash flow
HCM
HCM
$471.4M more FCF
HCM
$3.4M
$-468.0M
IREN

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
HCM
HCM
IREN
IREN
Revenue
$270.8M
$184.7M
Net Profit
$2.0M
$-155.4M
Gross Margin
37.7%
64.4%
Operating Margin
-13.2%
-63.0%
Net Margin
0.7%
-84.1%
Revenue YoY
-16.5%
59.0%
Net Profit YoY
-83.6%
-610.0%
EPS (diluted)
$0.00
$-0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
IREN
IREN
Q4 25
$270.8M
$184.7M
Q3 25
$240.3M
Q2 25
$277.7M
Q1 25
$324.5M
Q4 24
$116.1M
Q3 24
$52.8M
Q2 24
$305.7M
Q1 24
$54.3M
Net Profit
HCM
HCM
IREN
IREN
Q4 25
$2.0M
$-155.4M
Q3 25
$384.6M
Q2 25
$455.0M
Q1 25
$11.9M
Q4 24
$-21.9M
Q3 24
$-51.7M
Q2 24
$25.8M
Q1 24
$8.6M
Gross Margin
HCM
HCM
IREN
IREN
Q4 25
37.7%
64.4%
Q3 25
66.4%
Q2 25
0.1%
Q1 25
48.0%
Q4 24
72.2%
Q3 24
39.6%
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
IREN
IREN
Q4 25
-13.2%
-63.0%
Q3 25
-31.8%
Q2 25
-1.3%
Q1 25
-5.0%
Q4 24
14.9%
Q3 24
-89.2%
Q2 24
-9.0%
Q1 24
11.1%
Net Margin
HCM
HCM
IREN
IREN
Q4 25
0.7%
-84.1%
Q3 25
160.1%
Q2 25
163.8%
Q1 25
3.7%
Q4 24
-18.8%
Q3 24
-98.0%
Q2 24
8.4%
Q1 24
15.9%
EPS (diluted)
HCM
HCM
IREN
IREN
Q4 25
$0.00
$-0.52
Q3 25
$1.08
Q2 25
$0.52
Q1 25
$0.01
Q4 24
$-0.10
Q3 24
$-0.27
Q2 24
$0.03
Q1 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
IREN
IREN
Cash + ST InvestmentsLiquidity on hand
$1.4B
$3.3B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$2.5B
Total Assets
$1.8B
$7.0B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
IREN
IREN
Q4 25
$1.4B
$3.3B
Q3 25
$1.0B
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
$427.3M
Q3 24
$98.6M
Q2 24
$802.5M
Q1 24
$259.7M
Total Debt
HCM
HCM
IREN
IREN
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
IREN
IREN
Q4 25
$1.2B
$2.5B
Q3 25
$2.9B
Q2 25
$1.2B
Q1 25
$759.9M
Q4 24
$1.2B
Q3 24
$1.1B
Q2 24
$740.1M
Q1 24
$677.2M
Total Assets
HCM
HCM
IREN
IREN
Q4 25
$1.8B
$7.0B
Q3 25
$4.3B
Q2 25
$1.8B
Q1 25
$1.3B
Q4 24
$1.9B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$723.6M
Debt / Equity
HCM
HCM
IREN
IREN
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
IREN
IREN
Operating Cash FlowLast quarter
$8.2M
$71.7M
Free Cash FlowOCF − Capex
$3.4M
$-468.0M
FCF MarginFCF / Revenue
1.2%
-253.4%
Capex IntensityCapex / Revenue
1.8%
292.2%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-701.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
IREN
IREN
Q4 25
$8.2M
$71.7M
Q3 25
$142.4M
Q2 25
$-72.9M
Q1 25
$40.3M
Q4 24
$53.6M
Q3 24
$-3.9M
Q2 24
$-39.8M
Q1 24
$-27.1M
Free Cash Flow
HCM
HCM
IREN
IREN
Q4 25
$3.4M
$-468.0M
Q3 25
$-38.0M
Q2 25
$-82.2M
Q1 25
$32.5M
Q4 24
$-85.5M
Q3 24
$-109.7M
Q2 24
$-49.9M
Q1 24
$-108.3M
FCF Margin
HCM
HCM
IREN
IREN
Q4 25
1.2%
-253.4%
Q3 25
-15.8%
Q2 25
-29.6%
Q1 25
10.0%
Q4 24
-73.6%
Q3 24
-208.0%
Q2 24
-16.3%
Q1 24
-199.4%
Capex Intensity
HCM
HCM
IREN
IREN
Q4 25
1.8%
292.2%
Q3 25
75.0%
Q2 25
3.3%
Q1 25
2.4%
Q4 24
119.7%
Q3 24
200.6%
Q2 24
3.3%
Q1 24
149.5%
Cash Conversion
HCM
HCM
IREN
IREN
Q4 25
4.21×
Q3 25
0.37×
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
-1.54×
Q1 24
-3.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

IREN
IREN

Bitcoin Mining Revenue$167.4M91%
AI Cloud Services$17.3M9%

Related Comparisons